ICSE China 2015

Bringing outsourcing to CPhI China

ICSE China is dedicated to contract services by offering outsourcing solutions such as clinical trials, biotechnology and contract research.

Held alongside CPhI China, ICSE attracts international exhibitors who are keen to capitalise on the benefits of doing business in China. Besides contract manufacturing and contract research, other main services provided are packaging, clinical trials, laboratory services, drug discovery and marketing services. Whatever your function within the biotechnology or pharmaceutical industry, ICSE will show you how your organisation can benefit from outsourcing to China and enable you to arrange it .

China and the CRO&CMO industry

Global outsourcing favours China not only because of its relatively low cost but also because of the high quality human resources and daily-improving industry environment. China is the main origin of various pharmaceutical APIs and has a high level of technologies and capacity, including the powerful education system in physics and life sciences. Fast turnaround time, low costs and solutions of different clinical trials are highly preferred in the CRO industry for which China's R&D outsourcing market gives the perfect response.

ICSE China is the only specific theme exhibition held for the CRO&CMO industry. Being held concurrently with LABWorld China and BioPh China, it offers all pharmaceutical companies a one stop CRO&CMO outsourcing procurement platform and an excellent bridge for communication with industry peers and for exchanging latest industry information.

Stand options and booking

To find out the available stand options and prices, please contact